Quanta Therapeutics
San Francisco
About Quanta Therapeutics
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes. It develops allosteric modulation to directly restore conformational control of active RAS signaling at the cell membrane to inhibit the full scope of RAS-driven cancer types.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $140.7M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2023)
- Website: quantatx.com
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/quanta-therapeutics-60991 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.